Patents by Inventor Alexander Scriabine

Alexander Scriabine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of glomerulonephritis
    Patent number: 4840960
    Abstract: A method for treating a patient suffering from glomerulonephritis comprising administering to the patient an effective amount of nitrendipine.
    Type: Grant
    Filed: August 25, 1987
    Date of Patent: June 20, 1989
    Assignee: Miles Laboratories, Inc.
    Inventors: R. Bernd Sterzel, Alexander Scriabine
  • Method of treating hypertension
    Patent number: 4389415
    Abstract: A pharmaceutical composition containing .alpha.-methyl-p-tyrosine and carbidopa and method of treating hypertension are described.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: June 21, 1983
    Assignee: Merck & Co., Inc.
    Inventor: Alexander Scriabine
  • Anti-hypertensive compositions
    Patent number: 4163054
    Abstract: Novel pharmaceutical compositions are disclosed which comprise a hypotensive agent and a phenyl hydrazino substituted propionic acid decarboxylase inhibitor. The compositions have enhanced anti-hypertensive activity.
    Type: Grant
    Filed: October 12, 1977
    Date of Patent: July 31, 1979
    Assignee: Merck & Co., Inc.
    Inventor: Alexander Scriabine
  • Novel anti-hypertensive compositions
    Patent number: 4086354
    Abstract: Novel pharmaceutical compositions are disclosed which comprise a hypotensive agent and a phenyl hydrazino substituted propionic acid decarboxylase inhibitor. The compositions have enhanced anti-hypertensive activity.
    Type: Grant
    Filed: February 8, 1977
    Date of Patent: April 25, 1978
    Assignee: Merck & Co., Inc.
    Inventor: Alexander Scriabine
  • Novel anti-hypertensive compositions
    Patent number: 4055645
    Abstract: Novel pharmaceutical compositions are disclosed which comprise a hypotensive agent and a phenyl hydrazino substituted propionic acid decarboxylase inhibitor. The compositions have enhanced anti-hypertensive activity.
    Type: Grant
    Filed: February 13, 1976
    Date of Patent: October 25, 1977
    Assignee: Merck & Co., Inc.
    Inventor: Alexander Scriabine
  • Compositions and method of treating hypertension
    Patent number: 4016288
    Abstract: The present invention relates to a novel and useful method of treatment and a composition which is used to treat hypertension. More particularly, it relates to the administration of a composition containing (A) L-.alpha.-hydrazino-.alpha.-loweralkyl-3,4-dihydroxyphenyl propionic acid or .alpha.-hydrazino-3,4-dihydroxyphenyl propionic acid or a pharmaceutically acceptable non-toxic salt of either in combination with (B) a specific class of esters of .alpha.-methyl-3,4-dihydroxyphenylalaninate or a salt thereof.
    Type: Grant
    Filed: August 13, 1975
    Date of Patent: April 5, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Alexander Scriabine, Clement A. Stone